Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 196

Results For "RI"

10256 News Found

Nutricircle introduces nutrition based plant Protein isolates
News | March 18, 2023

Nutricircle introduces nutrition based plant Protein isolates

The objective of launching these products at AAHAR is to create awareness on the consumption of protein based products


Dr. Reddy's divests non-core brands in dermatology to Eris Lifesciences for Rs 275 Cr
News | March 17, 2023

Dr. Reddy's divests non-core brands in dermatology to Eris Lifesciences for Rs 275 Cr

Eris Lifesciences will be assigned the trademark of these brands by Dr. Reddy's for a consideration of Rs. 275 crore


ICMR approves Krivida Trivus to detect Influenza, SARS CoV2, and RSV
Public Health | March 17, 2023

ICMR approves Krivida Trivus to detect Influenza, SARS CoV2, and RSV

KRIVIDA TRIVUS detects the specific virus causing a respiratory infection.


Apollo Hospitals crosses the landmark of 10,000+ robotic surgeries
Healthcare | March 16, 2023

Apollo Hospitals crosses the landmark of 10,000+ robotic surgeries

Expands robotics to 20+ specialities


Glenmark Pharmaceuticals receives ANDA approval for Clindamycin Hydrochloride Capsules USP
Drug Approval | March 15, 2023

Glenmark Pharmaceuticals receives ANDA approval for Clindamycin Hydrochloride Capsules USP

Cleocin Hydrochloride Capsules market achieved annual sales of approximately US $33.6 million


Cepheid launches its first manufacturing unit in India
News | March 15, 2023

Cepheid launches its first manufacturing unit in India

The facility has been set up to manufacture tuberculosis testing cartridges


Philips and Gibraltar Health Authority announce 16-year strategic partnership
News | March 15, 2023

Philips and Gibraltar Health Authority announce 16-year strategic partnership

Patients will no longer need to travel abroad for treatment of acute cardiac diseases


LifeSigns raises Pre-Series A
News | March 15, 2023

LifeSigns raises Pre-Series A

A funding to expand operations and provide better patient care


Briefs: Lupin and Alembic
News | March 14, 2023

Briefs: Lupin and Alembic

Lupin Bioresearch Centre conducts BA/BE, PK/PD, In-vitro BE and biosimilar studies.


NATCO launches additional strengths for generic version of Revlimid in USA
News | March 10, 2023

NATCO launches additional strengths for generic version of Revlimid in USA

Lenalidomide capsules are a prescription medicine used in adults for the treatment of multiple myeloma.